Progyny Inc (PGNY)

Pretax margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Earnings before tax but after interest (EBT) (ttm) US$ in thousands 70,691 58,570 49,178 40,914 24,441 19,902 17,480 20,497 32,435 34,009 29,714 16,730 8,679 3,026 -9,981
Revenue (ttm) US$ in thousands 1,091,902 1,036,101 959,749 874,714 787,727 700,482 617,337 551,196 501,082 473,730 450,213 385,920 344,979 309,953 272,210
Pretax margin 6.47% 5.65% 5.12% 4.68% 3.10% 2.84% 2.83% 3.72% 6.47% 7.18% 6.60% 4.34% 2.52% 0.98% -3.67%

December 31, 2023 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $70,691K ÷ $1,091,902K
= 6.47%

Progyny Inc's pretax margin has shown a consistent positive trend over the past eight quarters, indicating improving profitability. The pretax margin has steadily increased from 3.11% in Q4 2022 to 6.49% in Q4 2023, demonstrating a strong upward trajectory. This suggests that the company has been successful in controlling its operating expenses and generating higher pre-tax profits relative to its revenue.

The pretax margin for Q4 2023 is the highest among the quarters analyzed, reflecting improved efficiency in managing costs and maximizing profitability. This positive trend in pretax margin is a favorable indicator of Progyny Inc's overall financial performance and ability to generate profits before accounting for taxes. Considering the consistent upward movement in pretax margin, Progyny Inc appears to be effectively leveraging its resources and optimizing its operations to enhance profitability.


Peer comparison

Dec 31, 2023

Company name
Symbol
Pretax margin
Progyny Inc
PGNY
6.47%
DaVita HealthCare Partners Inc
DVA
7.51%
Sotera Health Co
SHC
10.10%